✦ LIBER ✦

Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data

✍ Scribed by Boyce, Brendan; Xing, Lianping

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Benefits and Considerations of

✍ Fred Saad; Allan Lipton 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 338 KB

Bisphosphonates and RANK ligand inhibito

✍ H.L. Neville-Webbe; R.E. Coleman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 328 KB

EGFR Inhibitors in Cancer Treatment || C

✍ Ciardiello, Fortunato 📂 Article 📅 2012 🏛 Future Medicine Ltd ⚖ 776 KB

Bisphosphonates in the prevention and tr

✍ R.E. Coleman 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 657 KB

Clinical considerations for the use of a

✍ Peyman Hadji 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 499 KB

Bone-Targeted 2,6,9-Trisubstituted Purin

✍ Yihan Wang; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 97 KB 👁 1 views